DMAC icon

DiaMedica Therapeutics
DMAC

Overview Fund Activity

26 hedge funds and large institutions have $3.14M invested in DiaMedica Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
6
Closed
7
Calls
$10K
Puts
$11K
Net Calls
-$1K
Net Calls Change
-$119K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$44K
2
Citadel Advisors
2
Citadel Advisors
Florida
$43K
3
HF
3
HRT Financial
New York
$12K
4
Jane Street
4
Jane Street
New York
$12K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$229K

Top Sellers

1
SCM
1
Stonepine Capital Management
Oregon
$0
2
CF
2
Cantor Fitzgerald
New York
$0
3
SC
3
Shay Capital
New York
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$53K
5
Northern Trust
5
Northern Trust
Illinois
$112K
Name Holding Trade Value Shares
Change 		Shares
Change %
SCM
26
Stonepine Capital Management
Oregon
– -$2.38M -1,176,344 Closed
CF
27
Cantor Fitzgerald
New York
– -$30K -14,691 Closed
SC
28
Shay Capital
New York
– -$20K -10,000 Closed
PFGIA
29
Patriot Financial Group Insurance Agency
Massachusetts
– -$2K -1,300 Closed
NFSG
30
Newbridge Financial Services Group
Florida
– -$3K -1,269 Closed
1
2